|
Volumn 466, Issue 7309, 2010, Pages 903-
|
After the pandemic
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
INFLUENZA VACCINE;
COOPERATION;
DECISION MAKING;
DRUG INDUSTRY;
DRUG RESEARCH;
EDITORIAL;
GOVERNMENT;
INFLUENZA A (H1N1);
NATIONAL HEALTH ORGANIZATION;
PANDEMIC;
PRIORITY JOURNAL;
VIRUS MUTATION;
VIRUS STRAIN;
WORLD HEALTH ORGANIZATION;
EPIDEMIC;
HUMAN;
INFLUENZA VIRUS A H1N1;
INFLUENZA, HUMAN;
ORGANIZATION AND MANAGEMENT;
PATHOGENICITY;
PROCEDURES;
PUBLIC HEALTH;
PUBLIC HEALTH SERVICE;
STANDARDS;
VIROLOGY;
DISEASE OUTBREAKS;
DRUG INDUSTRY;
HUMANS;
INFLUENZA A VIRUS, H1N1 SUBTYPE;
INFLUENZA VACCINES;
INFLUENZA, HUMAN;
PUBLIC HEALTH;
PUBLIC HEALTH ADMINISTRATION;
WORLD HEALTH ORGANIZATION;
|
EID: 85052488922
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/466903b Document Type: Editorial |
Times cited : (3)
|
References (0)
|